Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
157.24
+9.47 (6.41%)
At close: Jul 17, 2026, 4:00 PM EDT
159.16
+1.92 (1.22%)
After-hours: Jul 17, 2026, 7:52 PM EDT
Palvella Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Reiterates $240 | Buy | Reiterates | $240 | +52.63% | Jul 1, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $227 | Buy | Reiterates | $227 | +44.37% | Jun 25, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $250 | Buy | Reiterates | $250 | +58.99% | Jun 24, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $205 | Buy | Reiterates | $205 | +30.37% | Jun 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $255 → $270 | Buy | Maintains | $255 → $270 | +71.71% | Jun 11, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 21, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $210 | Buy | Reiterates | $210 | +33.55% | May 21, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $240 | Buy | Reiterates | $240 | +52.63% | May 21, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.